Clinical trial
Isotretinoin in Treatment of COVID-19 (Randomized)
NCT04353180 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Isotretinoin in Treatment of COVID-19 (Randomized)
- Lead sponsor
- Kafrelsheikh University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- August 31, 2021
- Completion date
- November 30, 2021
- Enrollment
- 100,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
covid19